A couple of radiotracers we developed (C-11 and F-18 labeled) undergo extensive metabolism (less than 10 % intact tracer after 30 min pi). However, the radiometabolites didn't cross the BBB (hence no effect on the image acquired). In biodistributions study, we were also able to block 70 % to 90 % of the binding of the radiotracers in the target organ at 30 min pi with a structurally unrelated/different and validated compound. Hence, this rules out the contribution (significant) radiometabolites on the observed retention of radioactivity in the target organs. 

Here is the problem. Can this be considered a significant drawback of the radiotracers as a potential PET tracers? Could anyone give me a feedback on this (including citation will be a plus).

Any help is greatly appreciated. 

Similar questions and discussions